These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 477703

  • 1. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S, Buch J.
    Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
    [Abstract] [Full Text] [Related]

  • 2. [Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)].
    Vitolo E, Larovere MT, Gambini E, Rusconi F, Vitali GM.
    G Ital Cardiol; 1980 Aug; 10(10):1360-5. PubMed ID: 7239083
    [Abstract] [Full Text] [Related]

  • 3. Positive inotropic effect of K-canrenoate: an investigation in anaesthetized dogs, untreated or treated with digitalis.
    Marchetti G, Vitolo E, Di Francesco GF, Cavallaro B, Sponzilli C.
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):250-63. PubMed ID: 6667069
    [Abstract] [Full Text] [Related]

  • 4. [Aldosterone antagonists in coronary insufficiency].
    Osswald H.
    Med Klin; 1978 Jan 20; 73(3):84-8. PubMed ID: 622061
    [No Abstract] [Full Text] [Related]

  • 5. [Study of the inotropic effect of potassium canrenoate by determining systolic time intervals].
    Vitolo E, Gambini E, Larovere MT, Rusconi F, Vitali GM.
    Boll Soc Ital Cardiol; 1979 Jan 20; 24(7):775-7. PubMed ID: 554665
    [No Abstract] [Full Text] [Related]

  • 6. The role of potassium-canrenoate on 3H-noradrenaline uptake and metabolism of the rat heart.
    Préda I, Sebeszta M, Harsányi A, Szabó G, Antalóczy Z.
    Acta Physiol Acad Sci Hung; 1978 Jan 20; 51(4):393-9. PubMed ID: 754480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M, Cuppone R, Ricci GL.
    Arzneimittelforschung; 1988 Oct 20; 38(10):1492-5. PubMed ID: 3058132
    [Abstract] [Full Text] [Related]

  • 12. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
    Denis B, Machecourt J, Denis MC, Morena H, Pellet J, Rossignol B, Martin-Noël P.
    Arch Mal Coeur Vaiss; 1979 Sep 20; 72(9):1014-22. PubMed ID: 116612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Denis B, Dimitriou R, Machecourt J, Wolf JE, Page E, Reboud JP.
    Arch Mal Coeur Vaiss; 1984 Apr 20; 77 Spec No():35-40. PubMed ID: 6428361
    [Abstract] [Full Text] [Related]

  • 15. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 Apr 20; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
    Cristodorescu R, Gavrilescu S, Deutsch G, Berger E.
    Agressologie; 1978 Apr 20; 19(6):409-14. PubMed ID: 751526
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.